Antiprotozoal potential of Vismia species (Hypericaceae), medicinal plants used to fight cutaneous leishmaniasis

• Published in: Journal of ethnopharmacology Vol. 328; p. 118028
• Main Authors: Diel, Kriptsan Abdon Poletto, Santana Filho, Paulo Cesar, Pitol Silveira, Pablo, Ribeiro, Rafaela Laura, Teixeira, Paula Coelho, Rodrigues Júnior, Luiz Carlos, Marinho, Lucas C., Romão, Pedro Roosevelt Torres, von Poser, Gilsane Lino
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 28.06.2024
• Subjects: Anthraquinones; Antiprotozoal; Leishmaniasis; Physcion; Vismiaquinone; Vismiaquinone; Leishmaniasis; Physcion; Anthraquinones; Antiprotozoal
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2024.118028

Species of Vismia (Hypericaceae), known in Brazil as “lacre”, are commonly used in traditional Amazonian medicine for the treatment of skin lesions, including those caused by Leishmania infection. Hexane extracts from the leaves of Vismia cayennensis, V. gracilis, V. sandwithii and V. guianensis, as well as from the fruits of the latter, in addition to the anthraquinones vismiaquinone, physcion and chrysophanol isolated from these species were explored for their anti-promastigote and anti-amastigote activity on Leishmania amazonensis. Extracts were prepared by static maceration with n-hexane. The compounds, isolated by chromatographic techniques, were identified by spectroscopic methods (1H and 13C NMR). Promastigotes of L.amazonensis were incubated with hexane extracts (1–50 μg/mL) or anthraquinones (1–50 μM) and the parasite survival analyzed. The action of compounds on reactive oxygen species (ROS) production, mitochondrial membrane potential, and membrane integrity of promastigotes were evaluated by flow cytometer, and the cytotoxicity on mammalian cells using MTT assay. Furthermore, the activity of compounds against amastigotes and nitric oxide production were also investigated. Vismiaquinone and physcion were obtained from the leaves of V. guianensis. Physcion, as well as chrysophanol, were isolated from V. sandwithii. Vismia cayennensis and V. gracilis also showed vismiaquinone, compound detected in lower quantity in the fruits of V. guianensis. All extracts were active against the parasite, corroborating the popular use. The greatest activity against promastigotes was achieved with V. guianensis extract (IC50 4.3 μg/mL), precisely the most used Vismia species for treating cutaneous leishmaniasis. Vismiaquinone and physcion exhibited relevant activity with IC50 12.6 and 2.6 μM, respectively. Moreover, all extracts and anthraquinones tested induced ROS production, mitochondrial dysfunction, membrane disruption and were able to kill intracellular amastigote forms, being worthy of further in vivo studies as potential antileishmanial drugs. The overall data achieved in the current investigation scientifically validate the traditional use of Vismia species, mainly V. guianensis, as an anti-Leishmania agent. Furthermore, the promising results presented here indicate species of Vismia as potentially useful resources of Brazilian flora for the discovery of therapeutic solutions for neglected diseases. [Display omitted] •Vismia species are used for treating cutaneous leishmaniasis.•From the analyzed Vismia species, anthraquinones were obtained.•Among the anthraquinones evaluated, physcion presented the lowest IC50 value.•Vismia guianensis was the most active species against L. amazonensis.